more:science

Standardize the process.
Preserve the biology.

mo:re turns promising 3D models into controlled, reproducible, and documented protocols — helping teams bring advanced biology from expert hands into routine use.
 

From promising biology to routine use

A 3D model can work beautifully in expert hands and still be difficult to reproduce, transfer, and scale. The challenge is controlling technical execution without eliminating the biological variation that matters.
Handling, timing, reagent lots, and undocumented changes add technical noise. Donor- and disease-driven differences are often the signal you want to keep.

Control · Visualize · Scale · Document

01
Control

Automated, precise executionStandardize critical handling steps to reduce technical variability across wells, batches, users, and sites.

02
Visualize

Monitor the biology at critical checkpoints
Turn imaging and QC into measurable evidence that helps teams understand what is happening during the run.

03
Scale

Operationalize the method. Expand capacity
Scale across experiments, plates, users, and sites without proportional growth in expert hands-on time.

04
Document

Build traceability into every run
Link execution, imaging, QC, and data into a complete run record so methods can be compared, transferred, audited, and reproduced.

01 Control

Automated, precise execution.
Standardize critical handling steps to reduce technical variability across wells, batches, users, and sites.

02 Visualize

Monitor the biology at critical checkpoints.
Turn imaging and QC into measurable evidence that helps teams understand what is happening during the run.

03 Scale

Operationalize the method. Expand capacity.
Scale across experiments, plates, users, and sites without proportional growth in expert hands-on time.

04 Document

Build traceability into every run.
Link execution, imaging, QC, and data into a complete run record so methods can be compared, transferred, audited, and reproduced.

From innovation to routine use

The right starting point depends on how mature your method is, not on what kind of organization you are.

From innovation to routine use

Published evidence

Automated liver spheroid generation reduced the CV of spheroid area from 15.3% to 8.3% across independent runs, compared with manual handling.

Hellmold et al., Scientific Reports 16, 22707 (2026)
8.3% CV
vs. 15.3% manual

Latest from the lab

Header image
From Promising Model to Routine Use: MO:BOT Fits Every Step of the Pipeline
Patient-derived tumor spheroids for oncology drug screening
Patient-Derived Tumor Spheroids in Preclinical Oncology Drug Screening
Liver Organoids in Drug Discovery
Liver Organoids in Drug Discovery: From Hepatotoxicity Screening to Disease Modeling
Header image
From Promising Model to Routine Use: MO:BOT Fits Every Step of the Pipeline
Patient-derived tumor spheroids for oncology drug screening
Patient-Derived Tumor Spheroids in Preclinical Oncology Drug Screening
Liver Organoids in Drug Discovery
Liver Organoids in Drug Discovery: From Hepatotoxicity Screening to Disease Modeling
Organization Gilson
Logo Corning
Logo Bio Techne
Logo Promega
Logo Insphero

Tell us about your 3D workflow

Share the model and the method you want to run. A mo:re scientist will follow up to talk it through.